A new app called OneDrop that launched this month allows people with diabetes to track medication, food intake, insulin levels and exercise.
The app was created by Jeff Dachis, co-founder of digital marketing agency Razorfish, who was diagnosed with type 1 diabetes at the age of 47.
After failing to find an existing app that handled glucose testing, insulin medication and activity logging, Dachis set about creating OneDrop. The app allows people with type 1 and type 2 diabetes to either publicly, or anonymously, share information with other users.
As well as assisting the diabetes community and helping them learn from one another, OneDrop logs information such as the effectiveness of their medication and how recent activities, and food, might affect their blood sugar levels.
This information can therefore help the person with diabetes, and their healthcare team, determine a treatment plan that may be more effective.
Users can “like” certain activities on another’s profile, while stickers can also be sent to encourage users. A support component called “We” is also available.
The app is currently free, but Dachis is planning a monthly subscription later in 2016 that would include a Bluetooth-enabled glucose monitor and test strips.
“I’m wildly supportive of anyone looking to tackle the problem of diabetes,” Dachis told TechCrunch. “There’s a potential for half a billion people coming online with diabetes in the world. We spend half a trillion on complications related to diabetes.”

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…